Rod Franklin

Overlapping clinical definitions of the causes and characteristics of intradialytic hypertension make it a frustrating condition to diagnose and treat

Prominent cardiologist has some blunt advice for clinicians who are trying to apply JNC 7 guidelines in patients with CKD.

CKD stage is a predictor of incident AF and mortality risk in elderly patients. Patients with CKD also frequently exhibit major EKG abnormalities.

Peginesatide as effective as standard treatment for anemia in patients with kidney disease, but with higher risk for angina and arrhythmia.

SHARP trial shows that combination statin therapy in patients with CKD reduces risk of heart attack and stroke without raising cancer risk.

By targeting a novel inflammatory pathway, bardoxolone methyl can reduce the stage of chronic kidney disease and improve estimated glomerular filtration rate.

African Americans living in the poorest neighborhoods have double the risk of kidney transplant failure compared with white non-Hispanic patients.

Combo therapy with thiazide diuretics may be a major cause of symptomatic hyponatremia, especially in older females with prior cerebrovascular events.

Studies show tolvaptan treats significant dilutional hyponatremia and can improve patient performance in neurocognitive and gait tests.

Researchers continue to study the cardiovascular benefits associated with the DASH diet. Patients with CKD should adjust potassium intake.

Information on diagnostic and therapeutic approaches to hyponatremia, including tolvaptan and other VRAs, will be presented at this year's conference.

Evidence-based strategies can alleviate gaps in providers' knowledge of chronic kidney disease and diabetes in underserved patient populations.